Web2 days ago · The findings, published Tuesday in the journal Molecular Cell, identify a promising new target for treating cancers fueled by certain genetic mutations, including mutations in the BRCA1 and BRCA2 genes. The research could lead to new therapies that have fewer side effects and work against cancers that have grown resistant to existing … WebApr 9, 2024 · UT Health San Antonio has filed a patent application on the drug. The mice served as a model system of long-term dietary stress precipitated by the calorie-rich, sugary, and fatty Western diet. The familiar results of this stress are obesity, type 2 diabetes, and cardiovascular complications. “Lowering the mitochondrial magnesium mitigated ...
People Can
WebJun 30, 2024 · EraCal Therapeutics: a new drug candidate for obesity The start-up that developed the compound is a finalist for The Spinoff Prize. Elie Dolgin EraCal Therapeutics used zebrafish to identify... WebApr 9, 2024 · UT Health San Antonio has filed a patent application on the drug. The mice served as a model system of long-term dietary stress precipitated by the calorie-rich, … start engine pitch competition
Semaglutide is a Promising Drug Treatment for Chronic Weight Management
WebThe diabetes medication semaglutide was recently approved to treat obesity, and other potentially effective obesity medications are in the pipeline. Susan Z. Yanovski, MD, discusses the critical need for effective ways to treat and manage weight for people with diabetes. She also describes semaglutide and other new medications that could make ... WebApr 11, 2024 · Three drugs currently on the market have generated a good deal of “buzz” as weight-loss aids: Ozempic, Wegovy and Mounjaro. But at this time, the U.S. Food and Drug Administration has approved... Web2 days ago · Semaglutide was originally developed as a treatment for type 2 diabetes, which can be debilitating and even a killer. Likewise, obesity can be life-threatening. Treatments … startengine secondary market